Physician profile
Spencer Summers
NPI 1598128811
$75,158.41
in general payments reported to CMS, 2019-2025
13 companies · $34K in 2025
The $34K reported for 2025 was more than what 86% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,643 · 2021: $217 · 2022: $6,777 · 2023: $1,671 · 2024: $31K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $62K · Food and Beverage: $2,740 · Travel and Lodging: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,485.95 |
| Food and Beverage | $2,740.33 |
| Travel and Lodging | $1,295.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $61,617.74 | 2021-2025 | Attune, Velys |
| Depuy Synthes Products, INC. | $6,171.06 | 2022-2024 | |
| Stryker Corporation | $2,332.65 | 2021-2025 | Mako, Insignia, Exeter |
| Smith+Nephew, INC. | $1,728.17 | 2022-2025 | Journey II, Real Intelligence, Legion Revision |
| Southern Edge Orthopaedics, INC. | $1,643.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $763.21 | 2022-2024 | Mymobility Platform, Persona, Rosa |
| Depuy Synthes Sales INC. | $656.40 | 2022-2025 | Monovisc, Orthovisc, Attune |
| Microport Orthopedics INC | $107.28 | 2022 | |
| Biocomposites INC | $38.71 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $28.91 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.94 | 2025 | Exparel, Zilretta, Iovera |
| Heron Therapeutics, INC. | $23.47 | 2024 | Zynrelef |
| Ethicon US, LLC | $21.87 | 2023 | Vistaseal, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.